Armstrong, Fleming & Moore, Inc Novo Nordisk A S Put Options Transaction History
Armstrong, Fleming & Moore, Inc
- $184 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding NVO
# of Institutions
1,744Shares Held
337MCall Options Held
10.7MPut Options Held
16M-
Jennison Associates LLC18.9MShares$940 Million0.78% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$736 Million0.08% of portfolio
-
Loomis Sayles & CO L P12.6MShares$626 Million1.12% of portfolio
-
Morgan Stanley New York, NY12.3MShares$613 Million0.06% of portfolio
-
Capital International Investors Los Angeles, CA11.6MShares$579 Million0.14% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $112B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...